Linezolid resistance in a clinical isolate of Staphylococcus aureus

被引：846
|
作者：
Tsiodras, S
Gold, HS
Sakoulas, G
Eliopoulos, GM
Wennersten, C
Venkataraman, L
Moellering, RC
Ferraro, MJ
机构：
[1] Massachusetts Gen Hosp, Dept Pathol, Clin Microbiol Labs, Boston, MA 02114 USA
[2] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA
[3] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA
[4] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA
[5] Harvard Univ, Sch Med, Boston, MA USA
来源：
LANCET | 2001年 / 358卷 / 9277期
关键词：
D O I：
10.1016/S0140-6736(01)05410-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The new oxazolidinone antimicrobial, linezolid, has been approved for the treatment of infections caused by various gram-positive bacteria, including meticillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). Although instances of linezolid resistance in VRE have been reported, resistance has not been encountered among clinical isolates of S aureus. We have characterised an MRSA isolate resistant to linezolid that was recovered from a patient treated with this agent for dialysis-associated peritonitis.
引用
收藏
页码：207 / 208
页数：2
相关论文
共 50 条
  • [21] Linezolid resistance in clinical isolates of Staphylococcus haemolyticus
    Calvo, J.
    Cano, M.
    Marin, M.
    Cercenado, E.
    Martinez-Martinez, L.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S230 - S230
  • [22] Linezolid resistance in clinical isolates of Staphylococcus epidermidis
    Layer, F.
    Strommenger, B.
    Bender, J.
    Werner, G.
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2013, 303 : 104 - 104
  • [23] Clinical characteristics of linezolid-resistant Staphylococcus aureus infections
    Peeters, MJ
    Sarria, JC
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2005, 330 (02): : 102 - 104
  • [24] Inactivation of the Indigenous Methyltransferase RlmN in Staphylococcus aureus Increases Linezolid Resistance
    LaMarre, Jacqueline M.
    Howden, Benjamin P.
    Mankin, Alexander S.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (06) : 2989 - 2991
  • [25] Vancomycin and linezolid resistance among multidrug-resistant Staphylococcus aureus clinical isolates and interaction with neutrophils
    Al-Bdery, Alaa Shahid Jassim
    Mohammad, Ghaidaa Jihadi
    Hussen, Bashdar
    GENE REPORTS, 2020, 21
  • [26] Linezolid-resistance Staphylococcus aureus - Prevalence, Emerging Resistance Mechanisms, Challenges and Perspectives
    Rafique, Hassan
    Hussain, Nazim
    Saeed, Muhammad Usama
    Iqbal, Hafiz M. N.
    Azim, Gulfam
    Bilal, Muhammad
    JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2022,
  • [27] Linezolid-resistance Staphylococcus aureus - Prevalence, Emerging Resistance Mechanisms, Challenges and Perspectives
    Rafique, Hassan
    Hussain, Nazim
    Saeed, Muhammad Usama
    Iqbal, Hafiz M. N.
    Azim, Gulfam
    Bilal, Muhammad
    JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2022, 16 (03): : 1492 - 1505
  • [28] Characterization of the role of IS256 in the development of intermediate vancomycin resistance in a clinical Staphylococcus aureus isolate
    Nagel, M.
    Jansen, A.
    Tuerck, M.
    Bierbaum, G.
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2007, 297 : 65 - 66
  • [29] Resistance to Linezolid Is Mediated by the cfr Gene in the First Report of an Outbreak of Linezolid-Resistant Staphylococcus aureus
    Morales, Gracia
    Picazo, Juan J.
    Baos, Elvira
    Candel, Francisco J.
    Arribi, Ana
    Pelaez, Beatriz
    Andrade, Raquel
    de la Torre, Maria-Angeles
    Fereres, Jose
    Sanchez-Garcia, Miguel
    CLINICAL INFECTIOUS DISEASES, 2010, 50 (06) : 821 - 825
  • [30] Linezolid-resistant Staphylococcus capitis isolate
    Ibrahim, R.
    Waked, R.
    Choucair, J.
    Aubry, A.
    Laurent, F.
    Simoes, P. Martins
    Dupieux-Chabert, C.
    Haddad, E.
    INFECTIOUS DISEASES NOW, 2022, 52 (03): : 176 - 177
12345